Fungal Sensitization Is Associated with Increased Risk of Life-Threatening Asthma

Sarah K. Medrek, Christina C. Kao, Danny H. Yang, Nicola A. Hanania, Amit D. Parulekar

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background Fungal sensitization in patients with asthma has been associated with severe asthma and worse asthma outcomes. Objective The purpose of this study was to determine the relationship between fungal and nonfungal sensitization, asthma severity, and clinical outcomes. Methods A retrospective review of patients with asthma evaluated in an urban pulmonary subspecialty clinic in the United States was performed. Patients with fungal and nonfungal allergen sensitization were identified based on serum-specific immunoglobulin E (sIgE) testing. Demographic, clinical, laboratory, and spirometric data were obtained. The relationship between fungal sensitization and asthma outcomes was examined. Results Of 390 patients with asthma identified, 307 had sIgE testing, of whom 53 (17.3%) had fungal sensitization, 117 (38.1%) had nonfungal sensitization, and 137 (44.6%) had no sensitization. Patients with fungal sensitization were more likely to be sensitized to ≥5 allergens than patients with nonfungal sensitization (66% for fungal vs 29% for nonfungal, P <.001). Serum IgE concentrations were highest in patients with fungal sensitization compared with patients with no sensitization or nonfungal sensitization (median, 825, 42, and 203 IU/mL, respectively, P <.001). Fungal sensitized patients were more likely to require intensive care unit (ICU) admission and mechanical ventilation than those with no sensitization or nonfungal sensitization (13.2%, 3.7%, and 3.4%, respectively, for ICU admission, P =.02; 11.3%, 1.5%, and 0.9%, respectively, for ventilation, P <.001). Conclusions Fungal sensitization is common in patients with asthma in an urban setting and is associated with greater sensitization to nonfungal allergens and increased risk of life-threatening asthma.

Original languageEnglish (US)
Pages (from-to)1025-1031.e2
JournalJournal of Allergy and Clinical Immunology: In Practice
Volume5
Issue number4
DOIs
StatePublished - Jul 2017
Externally publishedYes

Fingerprint

Asthma
Allergens
Immunoglobulin E
Intensive Care Units
Serum
Artificial Respiration
Ventilation
Demography
Lung

Keywords

  • Allergens
  • Atopy
  • Serum-specific immunoglobulin E
  • Severe asthma

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Fungal Sensitization Is Associated with Increased Risk of Life-Threatening Asthma. / Medrek, Sarah K.; Kao, Christina C.; Yang, Danny H.; Hanania, Nicola A.; Parulekar, Amit D.

In: Journal of Allergy and Clinical Immunology: In Practice, Vol. 5, No. 4, 07.2017, p. 1025-1031.e2.

Research output: Contribution to journalArticle

Medrek, Sarah K. ; Kao, Christina C. ; Yang, Danny H. ; Hanania, Nicola A. ; Parulekar, Amit D. / Fungal Sensitization Is Associated with Increased Risk of Life-Threatening Asthma. In: Journal of Allergy and Clinical Immunology: In Practice. 2017 ; Vol. 5, No. 4. pp. 1025-1031.e2.
@article{cdfbc3c687a04d67b9824d36d06fac28,
title = "Fungal Sensitization Is Associated with Increased Risk of Life-Threatening Asthma",
abstract = "Background Fungal sensitization in patients with asthma has been associated with severe asthma and worse asthma outcomes. Objective The purpose of this study was to determine the relationship between fungal and nonfungal sensitization, asthma severity, and clinical outcomes. Methods A retrospective review of patients with asthma evaluated in an urban pulmonary subspecialty clinic in the United States was performed. Patients with fungal and nonfungal allergen sensitization were identified based on serum-specific immunoglobulin E (sIgE) testing. Demographic, clinical, laboratory, and spirometric data were obtained. The relationship between fungal sensitization and asthma outcomes was examined. Results Of 390 patients with asthma identified, 307 had sIgE testing, of whom 53 (17.3{\%}) had fungal sensitization, 117 (38.1{\%}) had nonfungal sensitization, and 137 (44.6{\%}) had no sensitization. Patients with fungal sensitization were more likely to be sensitized to ≥5 allergens than patients with nonfungal sensitization (66{\%} for fungal vs 29{\%} for nonfungal, P <.001). Serum IgE concentrations were highest in patients with fungal sensitization compared with patients with no sensitization or nonfungal sensitization (median, 825, 42, and 203 IU/mL, respectively, P <.001). Fungal sensitized patients were more likely to require intensive care unit (ICU) admission and mechanical ventilation than those with no sensitization or nonfungal sensitization (13.2{\%}, 3.7{\%}, and 3.4{\%}, respectively, for ICU admission, P =.02; 11.3{\%}, 1.5{\%}, and 0.9{\%}, respectively, for ventilation, P <.001). Conclusions Fungal sensitization is common in patients with asthma in an urban setting and is associated with greater sensitization to nonfungal allergens and increased risk of life-threatening asthma.",
keywords = "Allergens, Atopy, Serum-specific immunoglobulin E, Severe asthma",
author = "Medrek, {Sarah K.} and Kao, {Christina C.} and Yang, {Danny H.} and Hanania, {Nicola A.} and Parulekar, {Amit D.}",
year = "2017",
month = "7",
doi = "10.1016/j.jaip.2016.11.015",
language = "English (US)",
volume = "5",
pages = "1025--1031.e2",
journal = "Journal of Allergy and Clinical Immunology: In Practice",
issn = "2213-2198",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Fungal Sensitization Is Associated with Increased Risk of Life-Threatening Asthma

AU - Medrek, Sarah K.

AU - Kao, Christina C.

AU - Yang, Danny H.

AU - Hanania, Nicola A.

AU - Parulekar, Amit D.

PY - 2017/7

Y1 - 2017/7

N2 - Background Fungal sensitization in patients with asthma has been associated with severe asthma and worse asthma outcomes. Objective The purpose of this study was to determine the relationship between fungal and nonfungal sensitization, asthma severity, and clinical outcomes. Methods A retrospective review of patients with asthma evaluated in an urban pulmonary subspecialty clinic in the United States was performed. Patients with fungal and nonfungal allergen sensitization were identified based on serum-specific immunoglobulin E (sIgE) testing. Demographic, clinical, laboratory, and spirometric data were obtained. The relationship between fungal sensitization and asthma outcomes was examined. Results Of 390 patients with asthma identified, 307 had sIgE testing, of whom 53 (17.3%) had fungal sensitization, 117 (38.1%) had nonfungal sensitization, and 137 (44.6%) had no sensitization. Patients with fungal sensitization were more likely to be sensitized to ≥5 allergens than patients with nonfungal sensitization (66% for fungal vs 29% for nonfungal, P <.001). Serum IgE concentrations were highest in patients with fungal sensitization compared with patients with no sensitization or nonfungal sensitization (median, 825, 42, and 203 IU/mL, respectively, P <.001). Fungal sensitized patients were more likely to require intensive care unit (ICU) admission and mechanical ventilation than those with no sensitization or nonfungal sensitization (13.2%, 3.7%, and 3.4%, respectively, for ICU admission, P =.02; 11.3%, 1.5%, and 0.9%, respectively, for ventilation, P <.001). Conclusions Fungal sensitization is common in patients with asthma in an urban setting and is associated with greater sensitization to nonfungal allergens and increased risk of life-threatening asthma.

AB - Background Fungal sensitization in patients with asthma has been associated with severe asthma and worse asthma outcomes. Objective The purpose of this study was to determine the relationship between fungal and nonfungal sensitization, asthma severity, and clinical outcomes. Methods A retrospective review of patients with asthma evaluated in an urban pulmonary subspecialty clinic in the United States was performed. Patients with fungal and nonfungal allergen sensitization were identified based on serum-specific immunoglobulin E (sIgE) testing. Demographic, clinical, laboratory, and spirometric data were obtained. The relationship between fungal sensitization and asthma outcomes was examined. Results Of 390 patients with asthma identified, 307 had sIgE testing, of whom 53 (17.3%) had fungal sensitization, 117 (38.1%) had nonfungal sensitization, and 137 (44.6%) had no sensitization. Patients with fungal sensitization were more likely to be sensitized to ≥5 allergens than patients with nonfungal sensitization (66% for fungal vs 29% for nonfungal, P <.001). Serum IgE concentrations were highest in patients with fungal sensitization compared with patients with no sensitization or nonfungal sensitization (median, 825, 42, and 203 IU/mL, respectively, P <.001). Fungal sensitized patients were more likely to require intensive care unit (ICU) admission and mechanical ventilation than those with no sensitization or nonfungal sensitization (13.2%, 3.7%, and 3.4%, respectively, for ICU admission, P =.02; 11.3%, 1.5%, and 0.9%, respectively, for ventilation, P <.001). Conclusions Fungal sensitization is common in patients with asthma in an urban setting and is associated with greater sensitization to nonfungal allergens and increased risk of life-threatening asthma.

KW - Allergens

KW - Atopy

KW - Serum-specific immunoglobulin E

KW - Severe asthma

UR - http://www.scopus.com/inward/record.url?scp=85010818059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010818059&partnerID=8YFLogxK

U2 - 10.1016/j.jaip.2016.11.015

DO - 10.1016/j.jaip.2016.11.015

M3 - Article

C2 - 28017627

AN - SCOPUS:85010818059

VL - 5

SP - 1025-1031.e2

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

SN - 2213-2198

IS - 4

ER -